Literature DB >> 12654480

Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans.

A T Ulus1, A Aksoyek, M Ozkan, S F Katircioglu, S Basu.   

Abstract

Free radicals are believed to be involved in postsurgery-related complications. We studied whether cardiopulmonary bypass (CPB) operation has any immediate impact on the initiation of oxidative stress and inflammatory response by measuring isoprostanes and prostaglandin F2alpha during and 24 h following CPB. The levels of 8-iso-PGF2alpha (a major F2-isoprostane and biomarker of oxidative stress) and 15-keto-dihydro-PGF2alpha (a major metabolite of PGF2alpha and biomarker of inflammatory response) were measured in frequently collected plasma samples before, during, and up to 24 h postsurgery in 21 patients. 8-Iso-PGF2alpha levels significantly increased within 3 min (p <.0001) and continued until 50 min (p <.0001) during CPB. On the contrary, no significant increase of inflammatory response indicator, 15-keto-dihydro-PGF2alpha was found during and up to 24 h postoperatively. These findings establish an increased free radical-induced oxidative stress activity rather than inflammatory response after CPB.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654480     DOI: 10.1016/s0891-5849(03)00030-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  20 in total

Review 1.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

2.  Oxidative stress injury after on-pump cardiac surgery: effects of aortic cross clamp time and type of surgery.

Authors:  José García-de-la-Asunción; Ernesto Pastor; Jaime Perez-Griera; Francisco Javier Belda; Tania Moreno; Eva García-del-Olmo; Francisco Martí
Journal:  Redox Rep       Date:  2013       Impact factor: 4.412

3.  Obesity and oxidative stress predict AKI after cardiac surgery.

Authors:  Frederic T Billings; Mias Pretorius; Jonathan S Schildcrout; Nathaniel D Mercaldo; John G Byrne; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

4.  Association between oxidative stress and atrial fibrillation.

Authors:  Ayman Samman Tahhan; Pratik B Sandesara; Salim S Hayek; Ayman Alkhoder; Kaavya Chivukula; Muhammad Hammadah; Heval Mohamed-Kelli; Wesley T O'Neal; Matthew Topel; Nima Ghasemzadeh; Yi-An Ko; Hiroshi Aida; Mazen Gafeer; Laurence Sperling; Viola Vaccarino; Yongliang Liang; Dean P Jones; Arshed A Quyyumi
Journal:  Heart Rhythm       Date:  2017-07-27       Impact factor: 6.343

Review 5.  New approaches to neuroprotection in infant heart surgery.

Authors:  Erin L Albers; David P Bichell; Bethann McLaughlin
Journal:  Pediatr Res       Date:  2010-07       Impact factor: 3.756

Review 6.  Lone AF - Etiologic Factors and Genetic Insights into Pathophysiolgy.

Authors:  Babar Parvez; Dawood Darbar
Journal:  J Atr Fibrillation       Date:  2010-06-01

Review 7.  The isoprostanes--25 years later.

Authors:  Ginger L Milne; Qi Dai; L Jackson Roberts
Journal:  Biochim Biophys Acta       Date:  2014-10-30

8.  Role of inflammation and oxidative stress in atrial fibrillation.

Authors:  Jie Li; Joseph Solus; Qingxia Chen; Young Hee Rho; Ginger Milne; C Michael Stein; Dawood Darbar
Journal:  Heart Rhythm       Date:  2009-12-24       Impact factor: 6.343

9.  Postoperative acute kidney injury is associated with hemoglobinemia and an enhanced oxidative stress response.

Authors:  Frederic T Billings; Stephen K Ball; L Jackson Roberts; Mias Pretorius
Journal:  Free Radic Biol Med       Date:  2011-02-18       Impact factor: 7.376

Review 10.  Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.

Authors:  Jochen Bauer; Anne Ripperger; Stefan Frantz; Süleyman Ergün; Edzard Schwedhelm; Ralf A Benndorf
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.